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Introduction {#sec1}
============

*Aspergillus fumigatus* forms airborne spores (conidia) that humans typically clear in a silent and asymptomatic manner. Due to the growing number of humans that live in immune compromised states, *A. fumigatus* is the most common and lethal agent of mold pneumonia worldwide ([@bib6], [@bib46], [@bib48], [@bib80]). In humans and mice, sterilizing immunity against *A. fumigatus* conidia depends on the action of myeloid cells, primarily neutrophils, lung-infiltrating monocytes, and monocyte-derived dendritic cells (Mo-DCs), as well as alveolar macrophages; all lymphoid cells are redundant for host defense ([@bib14], [@bib31], [@bib46], [@bib55]). Phagocyte NADPH oxidase is central to fungal clearance, as evidenced by a 40%--55% lifetime prevalence of IA in patients with chronic granulomatous disease ([@bib52]). Reactive oxygen species (ROS) induce a regulated cell death process in neutrophil-engulfed conidia and thereby protect the respiratory tract from tissue-invasive hyphae and fungal dissemination ([@bib71]).

Using targeted cell depletion strategies based on murine C-C chemokine receptor 2 (CCR2) promoter-dependent diphtheria toxin receptor (DTR) transgene expression ([@bib14], [@bib31]), recent studies implicated CCR2^+^ inflammatory monocytes and Mo-DCs in sterilizing antifungal immunity, both by direct fungal killing and by regulating the lung inflammatory milieu ([@bib13], [@bib14]). Since depletion of CCR2^+^ cells diminished neutrophil antifungal activity, two models could explain these findings. First, CCR2^+^ monocytes and Mo-DCs could release mediators that act directly on neutrophils to enhance antifungal effector functions. Second, CCR2^+^ monocytes and Mo-DCs could mediate the recruitment or activation of a third cellular constituent that conditions the lung inflammatory milieu independent of contributions from CCR2^+^ monocytes and their derivatives. Here, we provide evidence for the second model and identify plasmacytoid DCs (pDCs) as a third leukocyte constituent that is essential for innate immune crosstalk and host defense against *A. fumigatus* in an otherwise immune competent host.

The mechanism by which pDCs contribute to antifungal immunity in the lung remains an open question. *In vitro*, human pDCs may spread over *A. fumigatus* hyphae to blunt fungal metabolic activity, and, in rare instances, undergo a cell death process that may result in extracellular traps ([@bib49], [@bib64]). Mice treated with a mAb (i.e., anti-PDCA-1 or anti-CD317) that primarily targets pDCs in the steady state, but likely targets additional leukocyte subsets under inflammatory conditions ([@bib4]), are susceptible to *A. fumigatus* challenge. In this study, we integrate pDCs into a model of innate immune crosstalk that is critical for defense against *A. fumigatus* in the lung. We found that fungus-infected Mo-DCs and neutrophils utilize Dectin-1and Card9 signaling to release C-X-C chemokine-9 (CXCL9) and responded to type I and type III interferon (IFN) signaling to release C-X-C chemokine-10 (CXCL10). These C-X-C chemokine receptor 3 (CXCR3) ligands promoted pDC egress from the circulation into the infected lung. Lung CXCR3^+^ pDCs enhanced neutrophil NADPH oxidase activity and fungal killing, preventing the formation of tissue-invasive hyphae and promoting sterilizing immunity. These findings integrate antifungal pDCs into a model of mucosal immune defense against inhaled molds.

Results {#sec2}
=======

Mo-DCs and Neutrophils Produce CXCL9 and CXCL10 during *A. fumigatus* Infection {#sec2.1}
-------------------------------------------------------------------------------

To examine specific contributions of CCR2^+^ monocytes and Mo-DCs to the lung inflammatory milieu during *A. fumigatus* challenge and to eliminate potential contributions of CCR2^+^ natural killer (NK) cell and CD8^+^ T cell subsets, we crossed the CCR2-DTR transgene to *Rag2* ^*−/−*^ interleukin-2 receptor γ chain^−/−^ mice. Lung homogenates of diphtheria toxin (DT)-treated CCR2-DTR^+/−^ *Rag2* ^*−/−*^ interleukin-2 receptor γ chain^−/−^ mice (CCR2-DTR^+/−^ *Rag2* ^−/−^ *Il2rg* ^−/−^) contained less CXCL10 (IP-10), CCL5 (RANTES), CCL17 (TARC), and CCL20 (MIP-3α) compared with DT-treated non-transgenic *Rag2* ^−/−^ *Il2rg* ^−/−^ littermates at 36 h post-infection (pi), as measured in a cytokine array ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B).

Because a *CXCL10* polymorphism is implicated in IA susceptibility in hematopoietic cell transplant recipients ([@bib15], [@bib54]), we measured lung levels of CXCL9 and CXCL10, both CXCR3 ligands, in naive and in fungus-infected C57BL6 mice. *A. fumigatus* challenge induced CXCL9 and CXCL10 expression in the lung, with a peak at 48 h pi ([Figure 1](#fig1){ref-type="fig"} A). To validate the multiplex array data, we ablated CCR2^+^ monocytes and Mo-DCs in CCR2-DTR^+/−^ *Rag2* ^*−/−*^ *Il2rg* ^−/−^ mice and observed a 50%--70% reduction in lung CXCL9 and CXCL10 levels at 48 h pi ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Ablation of CCR2^+^ monocytes and Mo-DCs in conventional CCR2-DTR^+/−^ (CCR2 depleter) mice that contain lymphoid lineage cells yielded nearly identical results ([Figures 1](#fig1){ref-type="fig"}B and 1C), consistent with the model that CCR2^+^ myeloid cells represent a major cellular source of CXCR3 ligands during acute *A. fumigatus* infection.Figure 1CCR2^+^ Mo-DCs and Neutrophils Produce CXCL9 and CXCL10 during *A. fumigatus* Challenge(A--C) Lung CXCL9 and CXCL10 levels in (A) C57BL6 mice (n = 5) at 0--72 h pi or (B and C) in DT-treated CCR2-DTR^+/−^ and non-Tg (CCR2-DTR^−/−^) littermates (n = 5) at 48 h pi with 3 × 10^7^ CEA10 conidia.(D) Representative plots of RFP (CXCL9) and BFP (CXCL10) expression in indicated lung leukocytes isolated from Rex3 Tg → C57BL6.SJL BM chimeric mice at baseline (naive, top row) and 48 h pi with 3 × 10^7^ CEA10 conidia (infected, bottom row). The blue and purple gates indicate the frequency of BFP^+^ (CXCL9^+^) and BFP^+^RFP^+^ (CXCL9^+^ CXCL10^+^) cells, respectively.(E and F) (E) The graphs indicate the frequency of CXCL9^−^ CXCL10^+^ and CXCL9^+^ CXCL10^+^ neutrophils, monocytes, Mo-DCs, and pDCs and (F) the cellular identity of all CXCL9^−^ CXCL10^+^ (top) and CXCL9^+^ CXCL10^+^ lung leukocytes (bottom) at 48 h pi.(G and H) Lung (G) CXCL9 and (H) CXCL10 levels in DT-treated ROSA26-iDTR^Mrp8-Cre^ → C57BL6.SJL (neutrophil depleter) or non-Cre ROSA26-iDTR littermates → C57BL 6.SJL (control) BM chimeric mice (n = 10) at 48 h pi with 3--4 × 10^7^ heat-killed swollen CEA10 conidia. Data from two independent experiments were pooled.(A--C, G, and H) Dots represent individual mice and data are presented as mean ± SEM. Statistical analysis: (A) Kruskal-Wallis test, time points compared with t = 0 h, (B, C, G, and H) Mann-Whitney test. See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

To visualize hematopoietic cellular sources of CXCL9 and CXCL10, we generated chimeric mice (REX3 Tg → C57BL6.SJL) in which radiosensitive hematopoietic cells encoded RFP and BFP transgenes that were driven by the *Cxcl9* and *Cxcl10* promoters, respectively ([@bib24]). Following *A. fumigatus* challenge, Mo-DCs were the major cell types that expressed the RFP and BFP transgenes, consistent with the CCR2^+^ cell ablation data in the CCR2-DTR^+/−^ *Rag2* ^−/−^ *Il2rg* ^−/−^ and CCR2-DTR^+/−^ backgrounds ([Figures 1](#fig1){ref-type="fig"}D--1F). The majority of Mo-DCs produced CXCL9 and CXCL10 simultaneously, whereas a minority were positive only for CXCL10 ([Figures 1](#fig1){ref-type="fig"}E and 1F). Monocytes expressed primarily the CXCL10 transgene, while CXCL9 transgene expression was undetectable at baseline and during fungal infection. Neutrophils expressed both reporter transgenes during respiratory fungal infection, albeit with a lower frequency compared with Mo-DCs. pDCs, CD4^+^ and CD8^+^ T cells, and NK cells expressed very low levels of the reporter transgenes, respectively ([Figures 1](#fig1){ref-type="fig"}D--1F, [S1](#mmc1){ref-type="supplementary-material"}D, and S1E).

To ascertain that neutrophils contribute to CXCL9 and CXCL10 production, we generated bone marrow (BM) chimera mice that enabled DT-induced neutrophil depletion (ROSA26-iDTR^Mrp8-Cre^ → C57BL6.SJL mice, neutrophil depleter) or not (non-Cre ROSA26-iDTR littermates → C57BL6.SJL) and measured CXCL9 and CXCL10 levels following challenge with heat-killed swollen *A. fumigatus* conidia 48 h pi. This experimental setup was utilized to eliminate potential differences in fungal growth observed in neutrophil depletion studies ([@bib5], [@bib14], [@bib53], [@bib55]). Neutrophil-depleted mice exhibited significantly lower CXCL10 lung levels compared with non-depleted littermates, though CXCL9 lung levels were similar ([Figures 1](#fig1){ref-type="fig"}G and 1H). Although CCR2^+^ Mo-DCs were the major cellular source of CXCL9 and CXCL10 during acute *A. fumigatus* challenge, neutrophils contributed to CXCL10 production as well.

Distinct Signaling Pathways Promote CXCL9 and CXCL10 Production by Fungus-Infected Myeloid Cells in the Lung {#sec2.2}
------------------------------------------------------------------------------------------------------------

To examine whether fungal uptake by Mo-DCs and neutrophils drives CXCL9 and CXCL10 expression, we infected chimeric REX3 Tg → C57BL6 mice with Alexa 633 (AF633)-labeled conidia and compared RFP and BFP expression in fungus-engaged (AF633^+^) and bystander (AF633^−^) leukocytes. Fungus-engaged Mo-DCs and neutrophils had much higher levels of fluorescent transgene expression than corresponding bystander cells had, indicating that fungal uptake promotes Mo-DC CXCL9 and CXCL10 production, neutrophil CXCL10 production ([Figures 2](#fig2){ref-type="fig"}A--2E), and, to a lesser extent, monocyte CXCL9 production ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B).Figure 2Fungal Uptake and Dectin-1 and Card9 and IFN Signaling Regulate Lung CXCL9 and CXCL10 Levels during *A. fumigatus* Infection(A--E) (A) Representative flow cytometry plots and bar graphs (B--E) that indicate the frequency of RFP^+^ (CXCL9^+^; red bar in B and C), RFP^−^ (CXCL9^−^; gray bar in B and C), BFP^+^ (CXCL10^+^; blue bar, in D and E), and BFP^−^ (CXCL10^−^; gray bar in D and E) bystander and fungus-engaged leukocytes isolated from (A, left column) naive or (A, middle and right column, B, and E) infected Rex3 Tg → C57BL6.SJL BM chimeric mice (n = 7) with 3 × 10^7^ AF633-labeled CEA10 conidia. The solid black gates in (A) indicate bystander neutrophils, whereas the solid blue gates indicate fungus-engaged leukocytes. The dashed line in the black and blue gate indicate CXCL9^+^ and CXCL9^−^ (top quadrants) leukocytes and CXCL10^+^ and CXCL10^−^ (bottom quadrants) leukocytes.(F) Lung CXCL9 and (G) CXCL10 levels in naive wild-type (WT, n = 5) and in WT (n = 10), *Clec7a*^*−/−*^ (n = 8), *Card9*^*−/−*^ (n = 7), *Ifnar1*^*−/−*^ (n = 9), and *Ifnlr*^−/−^ (n = 9) mice 48 h pi with 3 × 10^7^ CEA10 conidia. Data were pooled from two independent experiments.(B--G) Dots represent individual mice and data are presented as mean ± SEM. Statistical analysis: Mann-Whitney test. See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Dectin-1 is a major *A. fumigatus* recognition receptor by binding to β-glucan moieties that are exposed during conidial swelling, the first step in germination and hyphal formation ([@bib7], [@bib32], [@bib74], [@bib86]). Dectin-1 transduces signals via a cytoplasmic immunoreceptor tyrosine based activation motif (ITAM)-like motif that, upon tyrosine phosphorylation, activates spleen tyrosine kinase and Card9 ([@bib25], [@bib34], [@bib37], [@bib40], [@bib66]). To determine whether Dectin-1 and Card9 signaling mediates CXCL9 and CXCL10 production, we infected gene-deficient mice and found that CXCL9, but not CXCL10 production, was significantly attenuated in both *Clec7a* ^*−/−*^ and *Card9* ^*−/−*^ mice ([Figures 2](#fig2){ref-type="fig"}F and 2G), directly linking fungal recognition by C-type lectin receptor signaling to CXCL9 production in the lung.

Prior studies have demonstrated that CXCL10 expression can be induced in a variety of cells, including endothelial cells, keratinocytes, fibroblasts, mesangial cells, astrocytes, monocytes, and neutrophils by stimulation with IFN-α, IFN-β, IFN-γ, or lipopolysaccharide (LPS) and in T cells by antigen activation ([@bib10], [@bib50], [@bib58], [@bib62]). Since type I and type III IFN signaling are essential for host defense against *A. fumigatus* ([@bib13]), we measured CXCL10 production in IFN-signaling-deficient mice. Unlike CXCL9, lung CXCL10 levels were significantly reduced in *Ifnar1* ^*−/−*^ and in *Ifnlr* ^*−/−*^ mice ([Figures 2](#fig2){ref-type="fig"}F and 2G), indicating that distinct upstream signals couple fungal recognition to CXCL9 and CXCL10 production during acute *A. fumigatus* infection.

Since β-glucan recognition and IFN signaling may impact the number of Mo-DCs and neutrophils in *A. fumigatus*-infected lungs ([@bib37], [@bib38], [@bib86]), we sorted Mo-DCs and neutrophils from gene-deficient and wild-type mice and quantified *cxcl9* and *cxcl10* mRNA expression. Preliminary studies that measured *cxcl9* and *cxcl10* mRNA expression in Mo-DCs and neutrophils isolated from infected wild-type, *Clec7a* ^*−/−*^, *Ifnar* ^−/−^, and *Ifnlr* ^−/−^ mice supported the concept that β-glucan recognition and IFN signaling directly regulate *cxcl9* and *cxcl10* transcription, respectively (data not shown).

CXCR3 Is Critical for Survival and Fungal Clearance {#sec2.3}
---------------------------------------------------

To assess the relevance of CXCR3 ligand production ([@bib24]) for host outcomes, the survival of *Cxcr3* ^*−/−*^ mice was compared with *Cxcr3* ^*+/+*^ controls following *A. fumigatus* challenge. *Cxcr3* ^*−/−*^ mice were significantly more susceptible to challenge compared with controls ([Figure 3](#fig3){ref-type="fig"} A). The heightened susceptibility correlated with an increase in lung fungal burden ([Figures 3](#fig3){ref-type="fig"}B, [S3](#mmc1){ref-type="supplementary-material"}A, and S3B) and in lung tissue damage, as determined by comparisons of bronchoalveolar lavage fluid (BALF) lactate dehydrogenase (LDH) ([Figure 3](#fig3){ref-type="fig"}C) and albumin ([Figure 3](#fig3){ref-type="fig"}D) levels at 48 h pi or 72 h pi. These data linked *A. fumigatus*-triggered CXCL9 and CXCL10 production by Mo-DCs and neutrophils during acute *A. fumigatus* challenge to CXCR3-dependent protection and fungal clearance.Figure 3CXCR3 Is Critical for Anti-*Aspergillus* Defense(A) Kaplan-Meier survival of C57BL6 (n = 37) and *Cxcr3*^*−/−*^ (n = 35) mice challenged with 4--8 × 10^7^ CEA10 conidia. Data from three experiments were pooled.(B--D) (B) Normalized lung fungal burden, (C) BALF LDH level, and (D) BALF albumin levels in C57BL6 and *Cxcr3*^*−/−*^ mice 48 h pi with 3 × 10^7^ CEA10 conidia. (A--D) Dots represent individual mice and data were pooled from 2--4 experiments and presented as mean ± SEM. Statistical analysis: Mann-Whitney test. See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

CXCR3- and CCR2-Dependent Signals Mediate pDC Lung Recruitment {#sec2.4}
--------------------------------------------------------------

To define the cellular target of CXCR3 signaling, we measured CXCR3 expression on a wide range of leukocytes. BM-resident pDCs from naive mice and lung pDCs from *A. fumigatus*-infected mice expressed CXCR3, unlike other myeloid cell subsets analyzed ([Figure 4](#fig4){ref-type="fig"} A). As expected, CD4^+^ T cells, CD8^+^ T cells, and NK cells expressed CXCR3 ([Figure S4](#mmc1){ref-type="supplementary-material"}A), but mice that lack the lymphoid lineage (*Rag2* ^*−/−*^ *Il2rg* ^*−/−*^) did not exhibit heightened susceptibility to *A. fumigatus* challenge ([Figure S4](#mmc1){ref-type="supplementary-material"}B), as reported previously ([@bib14]).Figure 4CXCR3^+^ pDCs Traffic to *A. fumigatus*-Infected Lungs(A) CXCR3 surface expression in BM (top row) and lung (bottom row) leukocytes isolated from WT (black lines) or *Cxcr3*^*−/−*^ mice (purple lines).(B) Lung (blue filled dots) and BM (open black dots) pDC numbers at baseline and indicated times pi with 3 × 10^7^ CEA10 conidia (n = 5).(C) Lung pDC numbers in WT (open black dots) and *Cxcr3*^*−/−*^ mice (open purple dots) at 72 h pi (n = 10).(D) CCR2 surface expression in BM and lung pDCs in WT (black lines) or *Ccr2*^*−/−*^ mice (green lines).(E) Lung pDC numbers in WT (open black dots) and *Ccr2*^*−/−*^ mice (open green dots) at 72 h pi (n = 10).(B, C, and E) Data from 2--3 experiments were pooled and expressed as mean ± SEM. Statistical analysis: Mann-Whitney test. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Based on these results and published work ([@bib64]), we hypothesized that CXCR3-dependent pDC trafficking is critical for innate antifungal immunity. In prior studies, we did not identify pDCs in lung cell suspensions due to the inclusion of collagenase type IV. This preparation method degraded a pDC epitope utilized for their identification ([Figure S4](#mmc1){ref-type="supplementary-material"}C). Using a collagenase-free method to prepare single-cell lung suspensions, we observed that pDCs started to infiltrate *A. fumigatus*-infected lungs at 48 h pi, with a peak at 72 h pi ([Figure 4](#fig4){ref-type="fig"}B). pDC lung infiltration followed the observed peak in lung CXCL9 and CXCL10 levels and the peak influx of CXCL9- and CXCL10-producing innate immune cells ([Figures S4](#mmc1){ref-type="supplementary-material"}D--S4F). *Cxcr3* ^*−/−*^ mice exhibited a ∼50% reduction in lung pDCs ([Figure 4](#fig4){ref-type="fig"}C), whereas the number of lung monocytes, Mo-DCs, and neutrophils were similar to control mice at 72 h pi ([Figures S4](#mmc1){ref-type="supplementary-material"}G--S4I). CXCR3 surface expression was reduced on lung pDCs compared with circulating pDCs, consistent with the idea that CXCR3 surface expression is downregulated following engagement by CXCR3 ligands ([Figure 4](#fig4){ref-type="fig"}A). To examine whether CXCR3 acts in series or in parallel with other chemokine receptors to mediate pDC trafficking from the BM to the lung, we measured pDC surface expression of additional chemokine receptors in the resting and fungus-infected state. Consistent with prior studies ([@bib17], [@bib68], [@bib69], [@bib77]), we found that CCR2 is expressed by lung-infiltrating pDCs ([Figure 4](#fig4){ref-type="fig"}D). pDC lung recruitment was attenuated by 60%--70% in *Ccr2* ^*−/−*^ mice at 72 h pi compared with controls ([Figure 4](#fig4){ref-type="fig"}E). As expected ([@bib31]), lung monocyte and Mo-DC numbers were significantly reduced in *Ccr2* ^*−/−*^ mice ([Figures S4](#mmc1){ref-type="supplementary-material"}J and S4K), while lung neutrophil accumulation was not affected ([Figure S4](#mmc1){ref-type="supplementary-material"}L). In sum, these data indicate that CXCR3 and CCR2 both mediate pDC trafficking.

Sequential CCR2- and CXCR3-Dependent Signals Mediate pDC Lung Recruitment {#sec2.5}
-------------------------------------------------------------------------

To determine at which steps CXCR3 and CCR2 regulate pDC trafficking, we generated mixed BM chimeric mice to compare the trafficking of congenically marked gene-deficient (*Cxcr3* ^*−/−*^ or *Ccr2* ^−/−^) and gene-sufficient (*Cxcr3* ^*+/+*^ or *Ccr2* ^*+/+*^) pDCs ([Figure 5](#fig5){ref-type="fig"} A). In one model, CXCR3 and CCR2 may act in parallel at the same trafficking step. In this scenario, the ratio of gene-knockout to gene-sufficient pDCs would be increased in the same compartment for both chemokine receptors, prior to the dependent trafficking step. In an alternate model, CXCR3 and CCR2 may act in series at different trafficking steps. In this scenario, the ratio of gene-deficient to gene-sufficient pDCs would be elevated in distinct compartments.Figure 5Sequential CCR2- and CXCR3-Dependent Signals Mediate Lung pDC Recruitment(A) Experimental scheme to generate mixed BM chimeric mice and compare the trafficking of *Cxcr3*^−/−^, *Ccr2*^−/−^, and WT pDCs during *A. fumigatus* infection.(B and C) Relative frequencies of (B) *Cxcr3*^*−/−*^ (open purple bars) and *Cxcr3*^*+/+*^ (WT, open black bars) and (C) *Ccr2*^*−/−*^ (open green bars) and *Ccr2*^*+/+*^ (WT, open black bars) pDCs in the BM, blood, and lung of mixed BM chimeric mice 72 h pi. Data from 2--3 experiments were pooled and expressed as mean ± SEM. Statistical analysis: Mann-Whitney test. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

The ratio of *Cxcr3* ^*−/−*^ to *Cxcr3* ^*+/+*^ pDCs was elevated in the blood compared with the BM and lung compartments ([Figures 5](#fig5){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}A), both during infection and at baseline ([Figures 5](#fig5){ref-type="fig"}B and [S5](#mmc1){ref-type="supplementary-material"}A). These data support a model in which CXCR3 primarily, but not exclusively, mediates pDCs trafficking from the circulation into the lung in *A. fumigatus*-infected mice. In contrast to pDCs, the ratio *Cxcr3* ^*−/−*^ to *Cxcr3* ^*+/+*^ neutrophils and monocytes was similar in all compartments analyzed, consistent with CXCR3-independent trafficking ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C).

The ratio of *Ccr2* ^*−/−*^ to *Ccr2* ^*+/+*^ pDCs was elevated in BM compared with the blood and lung under all conditions examined. These data are consistent with a CCR2-dependent defect in pDC exit from the BM during infection ([Figure 5](#fig5){ref-type="fig"}C) and in the steady state ([Figure S5](#mmc1){ref-type="supplementary-material"}D). As anticipated, monocyte BM egress was highly dependent on CCR2 ([Figure 5SE](#mmc1){ref-type="supplementary-material"}), whereas neutrophil BM egress was not ([Figure S5](#mmc1){ref-type="supplementary-material"}F). In sum, these data show that CCR2- and CXCR3-dependent signals act in series to mediate pDC entry into the circulation and pDC egress from the circulation into the lung, respectively.

Lung pDCs Are Essential for Host Defense against *A. fumigatus* {#sec2.6}
---------------------------------------------------------------

To link CXCR3 signaling to pDC-dependent antifungal immunity, our model would predict that the chemokine receptor, CXCR3, and its cellular target, the pDC, are both essential for innate antifungal immunity. To test this conjecture, we infected BDCA2-DTR^+/−^ (pDC depleter) mice in which pDCs are ablated at rest and under inflammatory conditions ([@bib76]). Following DT treatment, pDCs were depleted fully in the steady state and at 72 h pi, whereas lung-infiltrating monocytes, Mo-DCs, neutrophils, and all other leukocyte subsets examined were not ([Figures 6](#fig6){ref-type="fig"}A--6E). In contrast to BDCA2-DTR^+/−^ mice, CCR2-DTR^+/−^ mice facilitated DT-induced ablation of pDCs in addition to other known CCR2^+^ cells, i.e., monocytes, Mo-DCs, and NK cells ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6E) ([@bib14], [@bib31]).Figure 6pDCs Are Critical for Anti-*Aspergillus* Defense(A--E) (A) Representative flow cytometry plots of B220^+^Siglec-H^+^ pDCs and (B) lung pDC, (C) lung monocyte, (D) lung Mo-DC, and (E) lung neutrophil numbers in DT-treated pDC depleter mice (BDCA2-DTR; open red symbols) and non-Tg littermate controls (open black symbols) at 72 h pi with 3 × 10^7^ CEA10 conidia.(F) Kaplan-Meier survival of DT-treated pDC depleter (n = 20) and non-Tg littermate control mice (n = 19) infected with 3--6 × 10^7^ CEA10 conidia.(G and H) (G) BALF LDH levels and (H) fungal burden of DT-treated pDC depleter (open red symbols; n = 6--18) or non-Tg littermates (control, open black symbols; n = 6--17) at 72 h pi with 3 × 10^7^ CEA10 conidia.(I) Lung fungal burden at 72 h pi with 3 × 10^7^ Af293 conidia.(J) Lung histopathology (top row, hematoxylin and eosin stain, scale bar: 800 μm; middle row, Gomori methenamine silver stain, scale bar: 800 μm; bottom row, GMS, scale bar: 200 μm) of DT-treated pDC depleter (right column; n = 6) or non-Tg littermates (Control, left column; n = 6) at 72 h pi with 3 × 10^7^ CEA10 conidia.(K and L) (K) Lung CXCL9 and (L) lung CXCL10 levels in DT-treated pDC depleter mice (red symbols) and non-Tg littermate controls (black symbols) at 72 h pi with 3 × 10^7^ CEA10 conidia.(B--L) Data were pooled from 2--3 independent experiments and expressed as mean ± SEM. Statistical analysis: Mann-Whitney test. See also [Figure S6](#mmc1){ref-type="supplementary-material"}.

To define the functional role of pDCs during *A. fumigatus* infection, we compared the mortality, lung LDH levels, lung fungal burden, and histopathology in pDC-depleted mice and in littermate controls. pDC-depleted mice were more susceptible to *A. fumigatus* challenge than control mice ([Figure 6](#fig6){ref-type="fig"}F), and mortality correlated with greater lung damage, as measured by BALF LDH levels ([Figure 6](#fig6){ref-type="fig"}G), an increased fungal burden following infection with two commonly used *A. fumigatus* isolates ([Figures 6](#fig6){ref-type="fig"}H and 6I), and a failure to control fungal germination in the lung at 72 h pi ([Figure 6](#fig6){ref-type="fig"}J). Importantly, pDCs did not contribute to the production of CXCL9 and CXCL10 in the lung during *A. fumigatus* challenge, as predicted by prior data ([Figures 6](#fig6){ref-type="fig"}K and 6L). In sum, CXCR3^+^ pDCs were essential for innate antifungal immunity in the lung after *A. fumigatus* challenge.

Lung pDCs Enhance Neutrophil Fungicidal Activity {#sec2.7}
------------------------------------------------

To determine how pDCs shape innate antifungal immunity in the lung, we hypothesized that pDCs are critical for antifungal effector functions, since lung neutrophil and Mo-DC numbers were unaffected in pDC-depleted mice. To test this hypothesis, we utilized the fluorescent *Aspergillus* reporter (FLARE) conidia that encode a dsRed viability fluorophore and are labeled with an Alexa Fluor 633 tracer (AF633). FLARE conidia enable us to distinguish live (DsRed^+^AF633^+^) and dead (DsRed^−^AF633^+^) conidia during cellular interactions with leukocytes with single-encounter resolution ([Figure 7](#fig7){ref-type="fig"} A). Using the FLARE strain, we quantified leukocyte conidial uptake and killing in pDC-depleted and littermate control mice. pDCs did not bind to or engulf *A. fumigatus* conidia, as measured by acquisition of AF633 fluorescence ([Figures 7](#fig7){ref-type="fig"}B and [S7](#mmc1){ref-type="supplementary-material"}A). pDC ablation did not affect lung neutrophil fungal uptake at 72 h pi compared with lung neutrophils in pDC-sufficient controls ([Figures 7](#fig7){ref-type="fig"}C and 7D). However, the frequency of neutrophils that contained live conidia was substantially increased in pDC-depleted mice compared with control mice ([Figures 7](#fig7){ref-type="fig"}C and 7E). In other words, neutrophil-engulfed conidia were more likely to be killed in control mice than in pDC-depleted mice ([Figures 7](#fig7){ref-type="fig"}C and 7E). pDC ablation did not alter conidial uptake or significantly reduce conidial killing by monocytes and Mo-DCs at 72 h pi ([Figures 7](#fig7){ref-type="fig"}D and 7E). These findings indicate that pDCs enhanced neutrophil fungicidal activity.Figure 7Lung pDCs Enhance Neutrophil Fungicidal Activity(A) Schematic of FLARE strain and changes in fluorescence emission following fungal uptake and killing by host leukocytes.(B) AF633 fluorescence intensity in indicated lung leukocytes 72 h pi with FLARE (blue line) or AF633-unlabeled conidia.(C) Representative plots that display dsRed and AF633 fluorescence intensity of lung neutrophils in DT-treated pDC depleter (right panel) and non-Tg littermates (left panel) 72 h pi with 3 × 10^7^ Af293 FLARE conidia. R1 denotes neutrophils that contain live conidia, R2 denotes neutrophils that contain killed conidia.(D and E) The plots show neutrophil, monocyte, and Mo-DC (D) conidial uptake (R1 + R2) ± SEM and (E) conidial viability (R1/ (R1 + R2) ± SEM in indicated lung leukocytes isolated from DT-treated pDC depleter (red symbols) and non-Tg littermates (black symbols) 72 h pi with 3 × 10^7^ FLARE conidia.(F and G) (F) Representative plot and (G) mean ± SEM neutrophil ROS production in cells isolated from DT-treated pDC depleter (right panel) and non-Tg littermates (left panel) 72 h pi with 3 × 10^7^ CEA10 conidia.(C--E) Data from 2 experiments were pooled.(F and G) Data are representative of two experiments.(D, E, and G) Dots represent individual mice and data are expressed as mean ± SEM. Statistical analysis: Mann-Whitney test. See also [Figure S7](#mmc1){ref-type="supplementary-material"}.

Neutrophils generate ROS via NADPH oxidase as a primary effector mechanism against *A. fumigatus* ([@bib52]). Neutrophil NADPH oxidase induces a regulated cell death process in *A. fumigatus* conidia ([@bib71]). To determine whether pDCs regulate the neutrophil oxidative burst in *A. fumigatus*-infected mice, we measured neutrophil ROS production in pDC-depleted mice. The ROS median fluorescence intensity in ROS^+^ lung neutrophils isolated from pDC-depleted mice was significantly reduced compared with ROS^+^ neutrophils isolated from littermate control mice at 72 h pi ([Figures 7](#fig7){ref-type="fig"}E and 7F). These data show that lung pDCs regulate neutrophil ROS generation during *A. fumigatus* challenge.

Discussion {#sec3}
==========

Humans maintain lifelong sterilizing immunity to inhaled mold conidia. Breaches in the respiratory innate immune system lead to mold pneumonia, a life-threatening disease in patients with functional or numeric deficits in myeloid cell function, particularly with the loss of the antifungal properties of neutrophils. In this study, we demonstrate a three-cell circuit that involves pDCs, monocytes and derivative Mo-DCs, and neutrophils to regulate sterilizing immunity against *Aspergillus* conidia. This circuit acts as a feedforward amplification mechanism, by coupling fungal recognition and fungus-induced inflammation to CXCR3 signaling-dependent pDC recruitment in the lung. pDCs regulate neutrophil ROS induction and fungal killing to mediate sterilizing immunity at the respiratory barrier.

Our data demonstrate that conidial uptake by lung-infiltrating monocytes and Mo-DCs triggered Dectin-1- and CARD9-dependent production of CXCL9 and type I and type III IFN signaling-dependent production of CXCL10; the latter process was readily detectable in neutrophils as well. The relative contribution of CXCL9 and CXCL10 and potential molecular redundancy with regard to downstream CXCR3-dependent processes during fungal infection remains an open question for future studies. Prior studies identified a polymorphism in the *Cxcl10* gene as a risk factor for IA in allogeneic hematopoietic cell transplant patients ([@bib15], [@bib54]). In this cohort, patients with IA had higher CXCL10 serum levels than controls that did not develop IA, consistent with the idea that pulmonary fungal infection induces CXCL10, similar to findings in mice in this work. Furthermore, the high-risk haplotype was associated with reduced *Cxcl10* mRNA expression by immature DCs (iDCs) co-cultured with *Aspergillus* germlings compared with wild-type iDCs ([@bib54]). Thus, human iDCs and murine lung Mo-DCs both responded to *A. fumigatus* challenge by transcribing *Cxcl10* mRNA. Although this process is generally regulated by IFN signaling in both mammalian species ([@bib57], [@bib59]), a recent study by Rivera and colleagues defined essential roles for type I and type III, but not type II, IFNs in murine host defense against *A. fumigatus* ([@bib13]). One model to account for these findings is that an early wave of type I IFN signaling, detected as early as 6 h pi in the lung and produced primarily by CCR2^+^ lung-infiltrating monocytes and Mo-DCs ([@bib13]), may drive CXCL10 release in the lung in a paracrine or autocrine manner, as observed in this study. In accordance with this model, CXCL10 lung levels that peak at 48 h pi are dependent on type I and type III IFN receptor signal transduction in the *Aspergillus*-infected murine lung.

Although IFN-dependent and -independent stimuli can induce CXCL9 during microbial infection ([@bib16], [@bib23]), previous studies have not directly linked C-type lectin receptor signaling to fungus-induced CXCL9 production. In murine models of experimental cryptococcosis with a wild-type or a recombinant vaccine strain that expresses human IFN-γ fungal infection led to lung CXCL9 and CXCL10 production, though the identity of chemokine-producing cells was not investigated ([@bib33], [@bib87]). In this model, *Card9* ^*−/−*^ mice had lower lung CXCL9 levels than control mice. This finding was attributed to reduced lung infiltration of IFN-γ-producing NK and CD4^+^ T cells because *Cryptococcus*-stimulated BM DCs failed to produce either cytokine *in vitro* ([@bib87]). In contrast, splenic and central nervous system (CNS)-resident Mo-DCs produced copious levels of CXCL9 and CXCL10 during murine cerebral malaria ([@bib30]). Because a significant fraction of CXCL9^+^CXCL10^+^ splenic Mo-DCs contained hemozoin, a malarial pigment, this study supported the idea that microbial uptake regulated CXCR3 ligand release either directly or indirectly in infected cells. The authors provided evidence for indirect CXCL9 and CXCL10 regulation since their secretion was highly dependent on intact IFN-γ receptor signaling. In the case of respiratory *A. fumigatus* infection, the dual regulation of CXCL9 by Dectin-1 and Card9 and of CXCL10 by type I and type III IFN signaling indicates both direct and indirect regulation of distinct CXCR3 ligands by a pathogen-associated molecular pattern receptor and soluble type I and type III IFNs.

CXCR3 ligands have been studied extensively in the context of CD4^+^ and CD8^+^ T cell trafficking in peripheral lymphoid and non-lymphoid tissues, in part due to high CXCR3 expression on effector and memory T cell subsets, in contrast to naive T cells ([@bib63]). In draining lymph nodes (LNs), antigen-activated and transferred DCs express CXCL9 and CXCL10 and thereby regulate the frequency of IFN-γ^+^ CD4^+^ T cells, linking the CXCR3 signaling axis to the formation of effector Th1 cells ([@bib24]). CXCR3 facilitated the entry of effector T cells into otherwise restricted sites, exemplified by CXCR3^+^ CD8^+^ T cells infiltration of the CNS or genital tract during murine malaria, West Nile virus, or herpes simplex virus 2 infection ([@bib30], [@bib56], [@bib78], [@bib79]). During bacterial infection, a study reported that CXCR3 signaling regulated neutrophil influx to the infected cecum and thus controlled *Salmonella* extra-intestinal dissemination ([@bib9]). In rodent models of viral (e.g., influenza virus or coronavirus) or chemical acute respiratory distress syndrome, CXCL10^+^ lung-infiltrating neutrophils and CXCL9^+^ macrophages mediated the recruitment of tissue-destructive CXCR3^+^ neutrophils; this pathologic process was ameliorated in *Cxcr3* ^*−/−*^ or *Cxcl10* ^−/−^ mice ([@bib35]). During respiratory fungal challenge, we did not observe CXCR3 expression on lung-infiltrating neutrophils and neutrophil recruitment was unaffected in *Cxcr3* ^*−/−*^ mice compared with control mice. In more recent work in the *Salmonella* model, infected splenic macrophages reside in T cell-sparse granulomas but are surrounded by mononuclear phagocytes that release CXCL9 and CXCL10 to recruit antigen-specific CXCR3^+^ Th1 cells for bacterial containment ([@bib21]). Thus, CXCR3 ligands target both innate and adaptive immune cells in a highly context-dependent manner; this process can result in microbial containment or microbe-elicited tissue damage.

pDCs originate in the BM, circulate in the blood, and traffic to lymphoid and non-lymphoid tissues under homeostatic and inflammatory conditions ([@bib17], [@bib73], [@bib77]). However, the mechanism that couples microbial recognition to pDC accumulation at peripheral sites has remained poorly understood. During respiratory fungal infection, neither CCR2^+^ monocytes nor CCR2^−^ neutrophils had the capacity to respond to CXCR3 ligands because these cells do not express CXCR3. Thus, the recruitment of lung-infiltrating monocytes and pDCs occurs via a pathway that bifurcated after the initial CCR2-dependent egress from the BM reservoir. Although the precise cues that regulate the CXCR3-independent entry of circulating monocytes into the fungus-infected lung remain unknown, integrin-mediated mechanisms enable monocytic influx into hepatic foci of *Listeria monocytogenes* during systemic infection ([@bib70]).

During other types of lung infections, e.g., influenza and respiratory syncytial virus (RSV), pDCs traffic to the lungs and draining LNs of mice ([@bib45], [@bib72], [@bib84]) via pathways that are distinct compared with conventional DCs ([@bib68], [@bib73]). For example, pDC LN trafficking during murine influenza is regulated primarily by L-selectin (CD62L), with contributions from CXCR3 and CXCR4. Further pDC positioning within the LN is mediated by CCR7 and the release of pDC-derived CXCR3 ligands to enable the formation of clusters of pDCs that interact and activate cells of the adaptive immune system ([@bib43]). In contrast, we did not observe pDC-dependent release of CXCL9 and CXCL10 in the *Aspergillus*-infected lung, consistent with the model that pDC recruitment cues depends on heterologous myeloid cells. Beyond CXCR3, L-selectin, and CXCR4, the E-selectin ligands, β1 and β2 integrins, CCR5, CCR7, and the chemerin receptor ChemR23 have been implicated in pDC trafficking during states of inflammation ([@bib12], [@bib42], [@bib73], [@bib81], [@bib85]), though it has remained unclear how individual cues cooperate to guide distinct pDC trafficking steps, and what the relative strength of individual cues is for defined tissue destinations and types of inflammatory stimuli. The sequential requirements for CCR2 and CXCR3 signaling in distinct pDC trafficking steps during respiratory *A. fumigatus* infection provides a combinatorial model, in which a more general cue for myeloid cell BM egress (i.e., CCR2 that acts on monocytes and pDCs) is combined with a more specific, pDC-targeted cue (i.e., CXCR3). The latter cue emanates primarily from CCR2^+^ Mo-DCs that were not equipped to control fungal tissue invasion or license the full spectrum of neutrophil antifungal activity per se.

pDCs were functionally characterized as mediators of antiviral defense ([@bib2], [@bib75]). Recent studies have expanded their role to antibacterial (e.g., *Legionella pneumophila*, *Chlamydia pneumoniae*, and *Staphylococcus aureus*) ([@bib1], [@bib11], [@bib60]) and to antifungal defense ([@bib1], [@bib33]). pDC-mediated antiviral responses are stimulated upon physical contact with infected cells ([@bib2]). pDCs adhere to infected cells via α~L~β~2~ integrin and ICAM-1 interactions, during which viral RNA is transferred to pDCs, leading to IFN production via the nucleic acid sensor TLR7. This process activates type I IFN-dependent antiviral programs in infected tissues. During respiratory fungal infection, lung-infiltrating pDCs do not interact directly with *Aspergillus* conidia but instead regulate neutrophils ROS induction. Our study does not exclude the possibility that *Aspergillus*- or host cell-derived nucleic acids activate pDCs in the lung *in situ*. Prior work has demonstrated that *Aspergillus*-derived unmethylated CpG sequences can activate TLR9 signaling *in vitro* ([@bib27], [@bib65]). Alternatively, pDCs may recognize fungal Dectin-2 (*Clec4n*) or Dectin-3 (*Clec4e*) ligands ([@bib49], [@bib51], [@bib61]). In patients with systemic lupus erythematosus, neutrophil-derived extracellular traps (NETs) activate pDCs by releasing DNA-protein complexes, resulting in TLR9-dependent release of pathologic type I IFNs during autoimmunity ([@bib18], [@bib44]). While *A. fumigatus* conidia are poor inducers of NETosis, products of germination, specifically hyphae that are too large to be phagocytosed, are potent stimuli for NETosis ([@bib3], [@bib8], [@bib19]). Thus, pDC activation in the fungus-infected lung likely occurs by multiple, yet undefined mechanisms.

The molecular basis for pDC-neutrophil crosstalk represents an important area of future investigation. Two non-exclusive models are likely operative. First, pDCs may form direct contact with neutrophils after arriving at the site of infection. In this model, an individual pDC would interact with many neutrophils since neutrophils are ∼100 times more prevalent in the lung at 48 h pi compared with pDCs. The relative paucity of pDCs, compared with other infiltrating myeloid cells (i.e., neutrophils and Mo-DCs), makes it unlikely that direct pDC-mediated fungistasis, observed at high effector to target cell ratios in the test tube, is physiologically significant in the fungus-infected lung ([@bib49], [@bib51]). Second, either fungus-triggered or host cell-triggered pDC activation may result in the release of soluble mediators that boost neutrophil fungicidal activity. Previous studies have identified GM-CSF, type I IFN, and type III IFN as important regulators of neutrophil NADPH oxidase activity during respiratory *A. fumigatus* and *B. dermatiditis* challenge ([@bib13], [@bib28], [@bib41]). The development of pDC-restricted Cre-lox candidate gene deletion strategies is essential to test these candidates formally.

In this study, we uncover essential functions for pDCs in innate antifungal defense that cannot be compensated by the presence of other myeloid cells, including neutrophils, monocytes, and Mo-DCs. In fact, fungus-engaged Mo-DCs and neutrophils harness pDCs as a feedforward amplification mechanism to enhance innate antifungal activity in the lung by coupling fungal recognition and fungus-induced inflammation to the CXCR3 signaling-dependent recruitment of pDCs into the fungus-infected lung. In the lung pDCs regulate neutrophil ROS induction, a process that induces a regulated cell death process in mold conidia ([@bib71]). Our findings indicate that pDC recovery following administration of chemotherapy and in BM transplant recipients may represent an important variable that affects infectious susceptibility not just to viral but also to fungal pathogens. Recent studies in BM transplant patients indicate that donor pDC reconstitution in the recipient is associated with favorable clinical outcomes, including non-relapse mortality from unrelated donors ([@bib22], [@bib82], [@bib83]). These data raise the possibility that pDC recovery in BM transplant patients may be important for controlling systemic fungal infections. Further studies to decipher the mechanistic role of pDCs in antifungal immunity is likely to inform strategies to harness these cells for prophylactic or therapeutic gain in vulnerable patient populations.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**APC Mouse anti-Mouse CD45.1 (clone A20)BD BioscienceCat\# 558701; RRID: [AB_1645214](nif-antibody:AB_1645214){#intref0010}PerCP-Cy™5.5 Mouse anti-Mouse CD45.2 (clone 104)BD BioscienceCat\# 552950; RRID: [AB_394528](nif-antibody:AB_394528){#intref0015}APC-Cy™7 Rat anti-Mouse CD45 (clone 30-F11)BD BioscienceCat\# 557659; RRID: [AB_396774](nif-antibody:AB_396774){#intref0020}PerCP-Cy™5.5 Rat anti-CD11b (clone M1/70)BD BioscienceCat\# 550993; RRID: [AB_394002](nif-antibody:AB_394002){#intref0025}PE-Cy™7 Hamster anti-Mouse CD11c (clone HL3)BD BioscienceCat\# 558079; RRID: [AB_647251](nif-antibody:AB_647251){#intref0030}BV 605™ anti-mouse CD11c Antibody (clone N418)BioLegendCat\# 117334; RRID: [AB_117334](nif-antibody:AB_117334){#intref0035}PE-Cy™7 Rat Anti-Mouse Ly-6C (clone AL-21)BD BioscienceCat\# 560593; RRID: [AB_1727557](nif-antibody:AB_1727557){#intref0040}FITC Rat anti-Mouse Ly-6G (clone 1A8)BD BioscienceCat\# 551460; RRID: [AB_394207](nif-antibody:AB_394207){#intref0045}FITC Rat anti-Mouse CD45R/B220 (clone RA3-6B2)BD BioscienceCat\# 553087; RRID: [AB_394617](nif-antibody:AB_394617){#intref0050}PE anti-mouse CD183 Antibody (clone CXCR3-173)BioLegendCat\# 126505; RRID: [AB_1027656](nif-antibody:AB_1027656){#intref0055}BV421 Rat Anti-Mouse Siglec-F (clone E50-2440)BD BioscienceCat\# 562681; RRID: [AB_2722581](nif-antibody:AB_2722581){#intref0060}BV605 Rat Anti-Mouse Siglec-H (clone 440c)BD BioscienceCat\# 747673; RRID: [AB_2744234](nif-antibody:AB_2744234){#intref0065}Purified Rat Anti-Mouse CD16/CD32 (clone 2.4G2)BD BioscienceCat\# 553142; RRID: [AB_394657](nif-antibody:AB_394657){#intref0070}eFluor 450 NK1.1 Monoclonal Antibody (clone PK136)eBioscienceCat\# 48-5941-80; RRID: [AB_2043878](nif-antibody:AB_2043878){#intref0075}eFluor 450 CD19 Monoclonal Antibody (clone eBio1D3)eBioscienceCat\# 48-0193-82; RRID: [AB_2734905](nif-antibody:AB_2734905){#intref0080}Alexa Fluor 700, I-A/I-E Monoclonal Antibody (clone M5/114.15.2)eBioscienceCat\# 56-53-21; RRID: [AB_494009](nif-antibody:AB_494009){#intref0085}FITC Mouse IgG1 kappa Isotype ControleBioscienceCat\# 11-4714-42; RRID: [AB_10596964](nif-antibody:AB_10596964){#intref0090}PE Rat IgG2a kappa Isotype ControleBioscienceCat\# 12-4321-42; RRID: [AB_1518773](nif-antibody:AB_1518773){#intref0095}PerCP-Cyanine5.5 IgG Isotype ControleBioscienceCat\# 45-4888-80; RRID: [AB_906260](nif-antibody:AB_906260){#intref0100}APC Rat IgG2b kappa Isotype ControleBioscienceCat\# 17-4031-82; RRID: [AB_470176](nif-antibody:AB_470176){#intref0105}APC-eFluor 780 Rat IgG2b kappa Isotype ControleBioscienceCat\# 47-4031-80; RRID: [AB_1272021](nif-antibody:AB_1272021){#intref0110}Alexa Fluor 700 Rat IgG2b kappa Isotype ControleBioscienceCat\# 56-4031-80; RRID: [AB_837123](nif-antibody:AB_837123){#intref0115}PE-Cyanine7 Rat IgG2a kappa Isotype ControleBioscienceCat\# 25-4321-82; RRID: [AB_470200](nif-antibody:AB_470200){#intref0120}eFluor 450 Rat IgG1 kappa Isotype ControleBioscienceCat\# 48-4301-82; RRID: [AB_1271984](nif-antibody:AB_1271984){#interref145}**Bacterial and Virus Strains**AF293Fungal Genetics Stock CenterCat\# A1100AF293 ds-Red([@bib38])N/ACEA10 (also known as CBS144.89)([@bib20])Received from Robert A. Cramer**Chemicals, Peptides, and Recombinant Proteins**Alexa Fluor 633 succinimidyl esterInvitrogenCat\# S12375Collagenase IVThermo Fisher ScientificCat\# LS004189RPMI-1640RPMI-164021870092EnrofloxacinBayerBaytril 100VoriconazolePfizerN/ATween-20SigmaP9416Protease Inhibitor CocktailRocheCat\# 11697498001DNase I, Grade IISigmaCat\# 10104159001BCG albumin assay kitSigmaMAK124IsofluraneHenry Schein Animal HealthCat\# 29405Diphtheria toxin (DT)List Biological LaboratoriesCat\# 150Paraformaldehyde, 32% SolutionThermo Fisher ScientificCat\# 50-980-495CM-H~2~DCFDAThermo Fisher ScientificCat\# C682710x HBSSThermo Fisher Scientific14065056TRIzol-LSInvitrogen10296028Mouse CXCL9/MIG DuoSet ELISAR&D SystemsDY492Mouse CXCL10/IP-10/CRG-2 DuoSet ELISAR&D SystemsDY466CytoTox96 non-radioactive cytotoxicity assay kitPromegaG1780High Capacity RNA-to-cDNA KitApplied Biosystems4387406Ribosomal RNA Control ReagentsApplied Biosystems4308329*Cxcl9* ASSAY ID: Mm01345159_m1Thermo Fisher4448892Cxcl10 ASSAY ID: Mm00445235_m1Thermo Fisher4453320**Experimental Models: Organisms/Strains***Cxcr3*^*-/-*^The Jackson LaboratoryJAX: 005796BDCA2-DTRThe Jackson LaboratoryJAX: 014176*Clec7a*^*-/-*^([@bib67])N/A*Card9*^*-/-*^([@bib34])JAX: 028652*Ccr2*^*-/-*^The Jackson LaboratoryJAX: 004999*Ifnar1*^*-/-*^The Jackson LaboratoryJAX: 32045*Ifnlr*^*-/-*^([@bib47])N/AC57BL6The Jackson LaboratoryJAX: 000664C57BL6.SJLCharles River LaboratoriesStock No. 564*Rag2*^*-/-*^*Il2rg*^*-/-*^TaconicStock No. 4111MRP8-Cre-IRES/GFPThe Jackson LaboratoryJAX: 021614ROSA26 iDTRThe Jackson LaboratoryJAX: 007900CCR2-DTR([@bib31])N/AREX3 Tg([@bib24])N/A**Software and Algorithms**Prism 8Prism 8N/AFlowJo 9.9.6FlowJo 9.9.6N/A

Resource Availability {#sec4.2}
---------------------

### Lead Contact {#sec4.2.1}

Further information and requests for resources or reagents should be directed to the Lead Contact, Tobias M. Hohl (<hohlt@mskcc.org>).

### Materials Availability {#sec4.2.2}

This study did not generate new unique reagents.

### Data and Code Availability {#sec4.2.3}

This study did not generate or analyze new datasets or codes.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Mice {#sec4.3.1}

*Cxcr3* ^*-/-*^, C57BL6 (CD45.2^+/+^), BDCA2-DTR mice were purchased from Jackson Laboratories (JAX: 014176). *Rag2* ^*-/-*^ *Il2rg* ^*-/*-^ mice (Stock No. 4111) were purchased from Taconic. *Ccr2* ^*-/-*^ (JAX: 004999) ([@bib69]), *Ifnar1* ^*-/-*^ (JAX: 32045) ([@bib39]), and *Ifnlr* ^*-/-*^([@bib47]) mice were provided by Dr. Eric Pamer (University of Chicago) and Dr. Sergei Kotenko (Rutgers), respectively. Bones from REX3 Tg (CXCL9-Red Red fluorescent protein and CXCL10-Blue fluorescent protein reporter) mice ([@bib24]) were provided by Dr. Andrew Luster (Massachusetts General Hospital). *Clec7a* ^*-/*^ ^*-*^ mice ([@bib67]) were provided by Dr. Shinobu Saijo (University of Tokyo). *Card9* ^*-/-*^ mice ([@bib34]) were provided by Dr. Xin Lin (Tsinghua University). MRP8-Cre-IRES/GFP and ROSA26 iDTR mice were crossed to generate ROSA26-iDTR^Mrp8-Cre^ mice. C57BL6 and C57BL6.SJL mice were crossed to generate CD45.1^+^CD45.2^+^ recipient mice for mixed BM chimeras. CCR2-DTR^+/−^ ([@bib31]) and non-transgenic littermates on the *Rag2* ^*-/-*^ *Il2rg* ^*-/-*^ background were maintained on amoxicillin- and Vitamin E-containing chow. All experiments with CCR2-DTR, CCR2-DTR *Rag2* ^*-/-*^ *Il2rg* ^*-/-*^ and BDCA2-DTR mice used co-housed littermate controls. For experiments in which the breeding strategy did not yield littermate controls, gene-knockout mice were co-housed with C57BL6 mice for 14 days prior to infection, whenever possible. All mouse strains were bred and housed in the MSKCC or Rutgers Research Animal Resource Center under specific pathogen-free conditions. All animal experiments were conducted with sex- and age-matched mice and performed with MSKCC or Rutgers Institutional Animal Care and Use Committee approval. Animal studies complied with all applicable provisions established by the Animal Welfare Act and the Public Health Services Policy on the Humane Care and Use of Laboratory Animals.

### Generation of Bone Marrow Chimeric Mice {#sec4.3.2}

For single BM chimeras, CD45.1^+^ C57BL6.SJL recipients were lethally irradiated (900cG), reconstituted with either 2-5 × 10^6^ CD45.2^+^ Rex3-Tg, CD45.2^+^ ROSA26-iDTR^Mrp8-Cre^, or CD45.2^+^ non-Cre iDTR littermates BM cells. For mixed BM chimeras, CD45.1^+^CD45.2^+^ recipients were irradiated and reconstituted with a 1:1 mixture of CD45.1^+^ C57BL6.SJL and CD45.2^+^ *Cxcr3* ^*-/-*^ or CD45.2^+^ *Ccr2* ^*-/-*^ BM cells. After BM transplantation, recipient mice received 400 μg/ml enrofloxacin in the drinking water for 21 days to prevent bacterial infections and rested for 6-8 weeks prior to experimental use.

### *Aspergillus fumigatus* culture and Infection Model {#sec4.3.3}

*A. fumigatus* Af293, Af293-dsRed ([@bib38]), and CEA10 ([@bib20]) strains were cultured on glucose minimal medium slants at 37^°^C for 4-7 days prior to harvesting conidia for experimental use. To generate FLARE conidia, briefly, 7 × 10^8^ Af293-dsRed conidia were rotated in 10 μg/ml Biotin XX, SSE in 1 ml of 50 mM carbonate buffer (pH 8.3) for 2 hr at 4°C, incubated with 20 μg/ml Alexa Fluor 633 succinimidyl ester at 37°C for 1 h, resuspended in PBS and 0.025% Tween 20 for use within 24 hr ([@bib29], [@bib36], [@bib38]). To generate morphologically uniform heat-killed swollen conidia, 5 × 10^6^/ml conidia were incubated at 37^°^C for 14 hours in RPMI-1640 and 0.5 μg/ml voriconazole and heat killed at 100°C for 30 minutes ([@bib32]). To infect mice with 30-60 million live or heat-killed *A. fumigatus* cells, conidia were resuspended in PBS, 0.025% Tween-20 at a concentration of 0.6-1.2 × 10^9^ cells and 50 μl of cell suspension was administered via the intranasal route to mice anesthetized by isoflurane inhalation.

Experimental Details {#sec4.4}
--------------------

### Analysis of *In Vivo* and *In Vitro* Conidial Uptake and Killing {#sec4.4.1}

To analyze of conidia uptake and killing, FLARE conidia were used to infect mice (*in vivo*) or co-culture with BM leukocyte (*in vitro*). In data analyses for a given leukocyte subset, conidial uptake refers to the frequency of fungus-engaged leukocytes, i.e. the sum of dsRed^+^AF633^+^ and dsRed^-^AF633^+^ leukocytes. Conidial viability within a specific leukocyte subset refers to the frequency of leukocytes that contain live conidia (dsRed^+^AF633^+^) divided by the frequency of all fungus-engaged leukocytes (dsRed^+^AF633^+^ and dsRed^-^AF633^+^).

### *In Vivo* Cell Depletion {#sec4.4.2}

To ablate specific cells, CCR2-DTR, CCR2-DTR, *Rag2* ^*-/-*^ *Il2rg* ^*-/-*^, ROSA26-iDTR^Mrp8-Cre^, BDCA2-DTR, and non-transgenic littermate controls were injected i.p. with 10 ng/g body weight DT on Day -1, Day 0, and Day +2 pi ([@bib13], [@bib76]), unless noted otherwise.

### Analysis of Infected Mice {#sec4.4.3}

Single cell lung suspensions were prepared for flow cytometry as described in ([@bib31]), with minor modifications. Briefly, perfused murine lungs were placed in a gentle MACS™ C tube and mechanically homogenized in 5 ml RPMI-1640, 10% FBS, and 0.1 mg/ml DNAse using a gentle MACS™ Octo Dissociator (Miltenyi Biotecc) in the absence of collagenase. Lung cell suspensions were lysed of RBCs, enumerated, and stained with fluorophore-conjugated antibodies prior to flow cytometric analysis on a BD LSR II or flow cytometric sorting on a BD Aria, flow plot analysis was performed using FlowJo v.9.6.6 software.

Neutrophils were identified as CD45^+^ CD11b^+^ Ly6C^lo^ Ly6G^+^ cells, inflammatory monocytes as CD45^+^ CD11b^+^ CD11c^-^ Ly6G^-^ Ly6C^hi^ cells, Mo-DCs as CD45^+^ CD11b^+^ CD11c^+^ Ly6G*^-^* Ly6C^hi^ MHC class II^+^ cells, and pDCs as CD45^+^ CD11c^int^ SiglecF^-^ CD19^-^ NK1.1^-^ CD11b^-^ B220^+^ SiglecH^+^ cells.

To analyze the lung fungal burden, perfused murine lungs were homogenized using a PowerGen 125 homogenizer (Fisher) in 2 mL PBS, 0.025% Tween-20, and plated on Sabouraud dextrose agar. To analyze cytokine levels by ELISA, whole lungs were weighed and mechanically homogenized in 2 mL PBS containing protease inhibitor. To analyze cytokine levels by qRT-PCR, total RNA from cells was extracted with TRIzol (Invitrogen). One to two micrograms of total RNA were reverse-transcribed using High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems). TaqMan Fast Universal Master Mix (2×), TaqMan probes (Applied Biosystems) for each gene were used and normalized to glyceraldehyde-3-phosphate dehydrogenase. Gene expression was calculated using the ΔΔCt method relative to the naïve sample. For histology, perfused lungs were fixed in 4% paraformaldehyde, embedded in paraffin, sectioned in 4 μm slices, stained with hematoxylin and eosin (H&E) or modified Gomori methenamine silver (GMS), and digitally scanned using a Zeiss Mirax Desk Scanner. Images were captured from whole slide images, acquired with an Aperio ScanScope (Aperio Technologies) using 5× and 20× objectives at the Molecular Cytology Core Facility (MSKCC). BAL LDH and albumin levels were measured with a CytoTox96 non-radioactive cytotoxicity assay kit and a BCG albumin assay kit, respectively.

### Reactive Oxygen Production {#sec4.4.4}

Intracellular ROS levels were measured in cells using CM-H2DCFDA \[5-(and 6-) chloromethyl-2,7-dichlorodihydrofluorescein diacetate, acetyl ester\] as described in ([@bib13], [@bib26]). Briefly, single cell lung suspensions were incubated with 1μM CM-H2DCFDA in Hanks' balanced salt solution at 37° C for 45 min according to manufacturer's instruction and analyzed by flow cytometry.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Data are representative of at least 2 independent experiments, as indicated. All results are expressed as mean (± SEM), unless stated otherwise. The Mann-Whitney test was used for comparisons of two groups, unless noted otherwise. The Kruskal-Wallis test was used for multi-group comparisons, unless noted otherwise. Survival data was analyzed by long-rank test. All statistical analyses were performed with GraphPad Prism software, v8.2.0.
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